CL2013000483A1 - Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico. - Google Patents

Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico.

Info

Publication number
CL2013000483A1
CL2013000483A1 CL2013000483A CL2013000483A CL2013000483A1 CL 2013000483 A1 CL2013000483 A1 CL 2013000483A1 CL 2013000483 A CL2013000483 A CL 2013000483A CL 2013000483 A CL2013000483 A CL 2013000483A CL 2013000483 A1 CL2013000483 A1 CL 2013000483A1
Authority
CL
Chile
Prior art keywords
cyclic peptide
radiolabelled
met
preparation
image forming
Prior art date
Application number
CL2013000483A
Other languages
English (en)
Spanish (es)
Inventor
Peter Brian Iveson
Rajiv Bhalla
Bard Indrevoll
Gareth Getvoldsen
Original Assignee
Ge Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ge Healthcare Ltd filed Critical Ge Healthcare Ltd
Publication of CL2013000483A1 publication Critical patent/CL2013000483A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nuclear Medicine (AREA)
CL2013000483A 2010-08-18 2013-02-18 Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico. CL2013000483A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1013808.9A GB201013808D0 (en) 2010-08-18 2010-08-18 Peptide radiotracer compositions

Publications (1)

Publication Number Publication Date
CL2013000483A1 true CL2013000483A1 (es) 2014-03-07

Family

ID=42938098

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013000483A CL2013000483A1 (es) 2010-08-18 2013-02-18 Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico.

Country Status (19)

Country Link
US (1) US9533059B2 (enExample)
EP (1) EP2605802B1 (enExample)
JP (1) JP6014592B2 (enExample)
KR (1) KR101853993B1 (enExample)
CN (1) CN103153350B (enExample)
AU (1) AU2011290856B2 (enExample)
BR (1) BR112013003469A2 (enExample)
CA (1) CA2807491C (enExample)
CL (1) CL2013000483A1 (enExample)
ES (1) ES2626410T3 (enExample)
GB (1) GB201013808D0 (enExample)
IL (1) IL224463A (enExample)
MX (1) MX348733B (enExample)
MY (1) MY163136A (enExample)
NZ (1) NZ606466A (enExample)
PH (1) PH12013500270A1 (enExample)
RU (1) RU2594167C2 (enExample)
SG (1) SG187878A1 (enExample)
WO (1) WO2012022676A1 (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201103696D0 (en) 2011-03-04 2011-04-20 Ge Healthcare Ltd Technetium labelled peptides
GB201121914D0 (en) 2011-12-20 2012-02-01 Ge Healthcare Ltd Method for patient selection
GB201209082D0 (en) * 2012-05-24 2012-07-04 Ge Healthcare Ltd Purification method
GB201221266D0 (en) * 2012-11-27 2013-01-09 Ge Healthcare Ltd Aldehyde compositions
GB201314936D0 (en) 2013-08-21 2013-10-02 Ge Healthcare Ltd Radiolabelling method
GB201322451D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Purification method and compositions
GB201322456D0 (en) * 2013-12-18 2014-02-05 Ge Healthcare Ltd Radiotracer compositions and methods
WO2018022603A1 (en) * 2016-07-25 2018-02-01 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of making 18f-labeled precursors and peptides, labeled c-met binding peptides, and methods of use thereof
GB201804835D0 (en) * 2018-03-26 2018-05-09 Ge Healthcare As Formulation and method of preparation
GB2598676A (en) 2019-06-14 2022-03-09 Edinburgh Molecular Imaging Ltd Compounds and methods of use
GB201915206D0 (en) * 2019-10-21 2019-12-04 Ge Healthcare Ltd Use of cyclodextrins as a radiostabilizer
SE2050387A1 (en) * 2020-04-06 2021-10-07 Pvac Medical Tech Ltd Labelled substance and methods of detection of inflammation and infection using said substance
TW202509086A (zh) * 2021-03-22 2025-03-01 日商肽夢想股份有限公司 c－Met蛋白質結合肽複合物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5961955A (en) * 1997-06-03 1999-10-05 Coulter Pharmaceutical, Inc. Radioprotectant for peptides labeled with radioisotope
AU2002357388A1 (en) 2001-12-27 2003-07-24 The United States Of America, As Represented By The Department Of Veterans Affairs Monoclonal antibody imaging and therapy of tumors that express met and bind hepatocyte growth factor
JP5466350B2 (ja) 2003-03-03 2014-04-09 ダイアックス、コープ ＨＧＦレセプター（ｃＭｅｔ）を特異的に結合するペプチドおよびその使用
GB0305704D0 (en) * 2003-03-13 2003-04-16 Amersham Plc Radiofluorination methods
GB0420344D0 (en) * 2004-09-14 2004-10-13 Amersham Plc Diagnostic compounds
JP2009542689A (ja) * 2006-07-07 2009-12-03 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 選択的カスパーゼ阻害剤
GB0615211D0 (en) 2006-07-31 2006-09-06 Ge Healthcare Uk Ltd Asymmetric flouro-substituted polymethine dyes
MX2009002492A (es) 2006-09-08 2009-08-28 Bayer Schering Pharma Ag Agentes que comprenden compuestos marcados con 18f y metodos relacionados.
WO2008072976A2 (en) 2006-12-13 2008-06-19 Ge Healthcare As Synthesis of a radiofluorinated peptide using microwave activation technology
WO2008083191A2 (en) * 2006-12-28 2008-07-10 Ge Healthcare As Radiofluorination methods
JP2010520229A (ja) 2007-03-01 2010-06-10 バイエル・シエーリング・ファーマ アクチエンゲゼルシャフト 放射性弗素化方法
AU2008249821B2 (en) 2007-05-16 2013-08-22 Ge Healthcare As Labelled HGF binding peptides for imaging
GB0718967D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Peptide imaging agents
GB0718957D0 (en) * 2007-09-28 2007-11-07 Ge Healthcare Ltd Optical imaging agents
GB0716897D0 (en) 2007-08-30 2007-10-10 Univ Muenchen Tech Cancer imaging and treatment
GB0803477D0 (en) * 2008-02-26 2008-04-02 Ge Healthcare As Therapy selection method

Also Published As

Publication number Publication date
GB201013808D0 (en) 2010-09-29
EP2605802B1 (en) 2017-04-26
KR101853993B1 (ko) 2018-05-02
RU2013105491A (ru) 2014-09-27
KR20130135242A (ko) 2013-12-10
JP6014592B2 (ja) 2016-10-25
CA2807491C (en) 2019-06-04
MY163136A (en) 2017-08-15
AU2011290856A1 (en) 2013-03-14
EP2605802A1 (en) 2013-06-26
CN103153350A (zh) 2013-06-12
BR112013003469A2 (pt) 2016-06-21
SG187878A1 (en) 2013-03-28
RU2594167C2 (ru) 2016-08-10
CN103153350B (zh) 2016-06-29
JP2013540702A (ja) 2013-11-07
MX348733B (es) 2017-06-27
WO2012022676A1 (en) 2012-02-23
MX2013001939A (es) 2013-03-18
IL224463A (en) 2016-05-31
ES2626410T3 (es) 2017-07-25
NZ606466A (en) 2014-11-28
AU2011290856B2 (en) 2014-12-04
CA2807491A1 (en) 2012-02-23
PH12013500270A1 (en) 2013-04-01
US9533059B2 (en) 2017-01-03
US20130149241A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
CL2013000483A1 (es) Agente de formación de imagen que comprende un péptido cíclico de enlace c-met radioetiquetado por 18f; composicion de agente de formación de imagen; precursor util en la formación del péptido cíclico; método para la preparacion del peptido cíclico.
EP2680059A4 (en) PICTURE MECHANISM, ENDOSCOPE, AND METHOD FOR PRODUCING IMAGE RECEIVING MECHANISM
BRPI1016132A2 (pt) composição, formulação farmacêutica, método para fabricar uma formulação farmacêutica estável.
IT1401367B1 (it) Metodo per combinare immagini riferentesi ad un contenuto tridimensionale.
BRPI1010261A2 (pt) agente e método de formação de imagem in vivo, composto precursos, métodos para a preparação de um composto precursor e do agente de formação de imagem in vivo, e para diagnostico de uma condição, kit, cassete,e , composição radiofarmaceutica.
BR112012000425A2 (pt) particulas de solução sólida de bronze de potássio-césio-tungstênio, processo para a preparação de partículas de solução sólida de bronze de potássio-césio-tungstênio, potássio-césio-tungstênio.
AR089558A1 (es) Construccion de listas de imagenes de referencia para codificar video
HUE046557T2 (hu) Tapentadolt tartalmazó vizes gyógyszerészeti készítmény szájon át alkalmazásra
EP2603834A4 (en) PROCESS FOR PRODUCING PICTURES
BR112013015796A2 (pt) composição de agente de formação de imagem, método de preparar uma composição de agente de formação de imagem, método de preparar um quelante 18f-nota, e, composição farmacêutica.
BRPI1007487A2 (pt) composição para radiomarcar ácido dietilenotriaminopentacético (dtpa)-dextrano
CL2013001085A1 (es) Un metodo para modular la concentracion de una o mas hormonas en un sujeto que comprende la administracion de una composicion que comprende un ligando del receptor quimiosensorial, donde la composicion esta adaptada para suministrar el ligando a una o mas regiones del intestino de tal sujeto.
EP2964722A4 (en) PROCESS FOR PROVIDING QUANTUM POINTS (QD)
BRPI0916936A8 (pt) composições faramacêuticas e métodos para produzir baixas concentrações de impureza das mesmas.
TWI371536B (en) Ball retainer chain, its manufacturing method used by being integrated to the linear motion mechanism
CL2014000328A1 (es) Metodo para preparar composicion que contiene un portador de oxigeno termoestable; composicion farmacéutica que comprende hemoglobina.
DK3564378T5 (da) Immunogen sammensætning
BRPI1007211A2 (pt) composição farmacêutica oral em uma forma sólida, e, processo para preparar uma composição.
HUE047995T2 (hu) Dinamikus képkódoló készülék, dinamikus képkódoló eljárás, dinamikus képkódoló program
ZA201306480B (en) Semisolid aqueous pharmaceutical composition containing tapentadol
BR112012003280A2 (pt) composição farmacêutica para administração oral, método para tratar uma doença, uso do composto, e, composto.
BR112013007237A2 (pt) ''método para produzir um anticorpo anti-ig-1r''
BRPI1011531A2 (pt) composto, e , método para fluoração de 18f.
BR112013031575A2 (pt) composto peptídico ciclado de estrutura principal, composição farmacêutica, uso de composto, e, processo para a manufatura de um composto.
BR112013013285A2 (pt) agente de formação de imagem, precursor, métodos de preparação do agente de formação de imagem, e de formação de imagem, composição radiofarmacêutica, kit para a preparação da composição radiofarmacêutica, e, uso do agente de formação de imagem